lifestance health is a behavioral health care company focused on providing evidenced-based, medically driven treatment services for children, adolescents and adults suffering from a variety of mental health issues in care settings that include acute inpatient, partial hospitalization, intensive outpatient, outpatient, community-based and in-home. at lifestance, patient care is paramount – the driving force in everything we do. we are committed to state-of-the-art clinical excellence, to partnership and collaboration with other treating health care providers to ensure continuity of care, to utilization of data to individually tailor our services for continual improvement in outcomes, and to empowering our patients to make informed choices and help them achieve their goals. all in a compassionate and safe environment that provides education, support and best practices in integrated care.
Company profile
Ticker
LFST
Exchange
Website
CEO
Kenneth Alan Burdick
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
LifeStance TopCo, L.P. • LifeStance Ultimate Holdings, Inc. • Lynnwood Intermediate Holdings, Inc. • LifeStance Health Holdings, Inc. • LifeStance Health, Inc. • Balance Women's Health, LLC • LifeStance Health – Nevada, LLC • LifeStance Health – Wisconsin, LLC • Advent Medical Group, LLC • LifeStance Health – Arizona, LLC ...
LFST stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
12 Mar 24
S-8
Registration of securities for employees
28 Feb 24
10-K
2023 FY
Annual report
28 Feb 24
8-K
LifeStance Reports Fourth Quarter and Full Year 2023 Results
27 Feb 24
8-K
Results of Operations and Financial Condition
2 Feb 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
LifeStance Reports Third Quarter 2023 Results
7 Nov 23
UPLOAD
Letter from SEC
6 Oct 23
CORRESP
Correspondence with SEC
5 Oct 23
UPLOAD
Letter from SEC
3 Oct 23
Transcripts
LFST
Earnings call transcript
2023 Q4
28 Feb 24
LFST
Earnings call transcript
2023 Q3
8 Nov 23
LFST
Earnings call transcript
2023 Q2
9 Aug 23
LFST
Earnings call transcript
2023 Q1
10 May 23
LFST
Earnings call transcript
2022 Q4
8 Mar 23
LFST
Earnings call transcript
2022 Q3
13 Nov 22
LFST
Earnings call transcript
2022 Q2
13 Aug 22
LFST
Earnings call transcript
2022 Q1
10 May 22
LFST
Earnings call transcript
2021 Q4
11 Mar 22
LFST
Earnings call transcript
2021 Q3
9 Nov 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 42.61 mm | 42.61 mm | 42.61 mm | 42.61 mm | 42.61 mm | 42.61 mm |
Cash burn (monthly) | 12.33 mm | 3.98 mm | 25.99 mm | 18.50 mm | 8.45 mm | (no burn) |
Cash used (since last report) | 83.66 mm | 26.98 mm | 176.29 mm | 125.48 mm | 57.33 mm | n/a |
Cash remaining | -41.05 mm | 15.62 mm | -133.68 mm | -82.87 mm | -14.72 mm | n/a |
Runway (months of cash) | -3.3 | 3.9 | -5.1 | -4.5 | -1.7 | n/a |
Institutional ownership, Q2 2023
81.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 109 |
Opened positions | 29 |
Closed positions | 10 |
Increased positions | 52 |
Reduced positions | 15 |
13F shares | Current |
---|---|
Total value | 2.65 tn |
Total shares | 310.45 mm |
Total puts | 164.30 k |
Total calls | 62.30 k |
Total put/call ratio | 2.6 |
Largest owners | Shares | Value |
---|---|---|
TPG GP A | 175.28 mm | $1.60 tn |
Summit Partners L P | 45.73 mm | $417.56 bn |
FMR | 26.42 mm | $241.22 bn |
Silversmith Partners I GP | 19.54 mm | $186.03 mm |
Vanguard | 7.44 mm | $67.93 bn |
BLK Blackrock | 7.09 mm | $64.76 bn |
PFG Principal Financial Group Inc - Registered Shares | 3.73 mm | $34.03 bn |
Stockbridge Partners | 3.69 mm | $33.66 bn |
Rock Springs Capital Management | 2.90 mm | $26.48 bn |
Geode Capital Management | 2.26 mm | $20.65 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | Kevin Michael Mullins | Common Stock | Sell | Dispose S | No | No | 5.93 | 9,688 | 57.45 k | 4,735,664 |
1 Apr 24 | Pablo Pantaleoni | Common Stock | Sell | Dispose S | No | No | 5.93 | 10,116 | 59.99 k | 1,299,927 |
1 Apr 24 | Ryan Pardo | Common Stock | Sell | Dispose S | No | No | 5.93 | 9,830 | 58.29 k | 807,947 |
1 Apr 24 | Danish J. Qureshi | Common Stock | Sell | Dispose S | No | No | 5.93 | 12,965 | 76.88 k | 4,911,050 |
15 Mar 24 | Kenneth A Burdick | Common Stock | Sell | Dispose S | No | No | 6.28 | 214,605 | 1.35 mm | 2,934,372 |
News
Morgan Stanley Reiterates Overweight on LifeStance Health Gr, Maintains $10 Price Target
22 Apr 24
Lifeist Reports Highest Quarterly Gross Profit In History, Continues To Diversify Its Wellness Business
2 Apr 24
Jefferies Maintains Buy on LifeStance Health Gr, Raises Price Target to $9
6 Mar 24
Goldman Sachs Maintains Neutral on LifeStance Health Gr, Raises Price Target to $9
4 Mar 24
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
28 Feb 24
Press releases
LifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024
18 Apr 24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFST
11 Mar 24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFST
7 Mar 24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFST
3 Mar 24
LifeStance Reports Fourth Quarter and Full Year 2023 Results
28 Feb 24